Biotech Target N V - Jan 19, 2023 Form 4 Insider Report for MACROGENICS INC (MGNX)

Role
10%+ Owner
Signature
/s/Ivo Betschart
Stock symbol
MGNX
Transactions as of
Jan 19, 2023
Transactions value $
$794,925
Form type
4
Date filed
1/23/2023, 03:21 PM
Previous filing
Dec 28, 2022
Next filing
Feb 16, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MGNX Common Stock Purchase $795K +150K +1.68% $5.30 9.08M Jan 19, 2023 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Remarks:

Biotech Target N.V. is a wholly-owned subsidiary of BB Biotech AG. Accordingly, BB Biotech AG may be deemed to be the indirect beneficial owner of the securities of MacroGenics, Inc. held directly or indirectly by Biotech Target N.V. This Form 4 is filed jointly by BB Biotech AG and Biotech Target N.V.